Cargando…

Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression

To find an association between genomic features of connective tissue and pejorative clinical outcomes on radical prostatectomy specimens. We performed a retrospective analysis of patients who underwent radical prostatectomy and underwent a Decipher transcriptomic test for localized prostate cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Treacy, Patrick-Julien, Martini, Alberto, Falagario, Ugo Giovanni, Ratnani, Parita, Wajswol, Ethan, Beksac, Alp Tuna, Wiklund, Peter, Nair, Sujit, Kyprianou, Natasha, Durand, Matthieu, Tewari, Ashutosh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139147/ https://www.ncbi.nlm.nih.gov/pubmed/37108678 http://dx.doi.org/10.3390/ijms24087520

Ejemplares similares

Value of multiphoton microscopy in uro-oncology: a narrative review
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients
por: Chakravarty, Dimple, et al.
Publicado: (2021)

Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
por: Dovey, Zachary, et al.
Publicado: (2020)

Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer
por: Beksac, Alp Tuna, et al.
Publicado: (2021)

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020)

A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy
por: Martini, Alberto, et al.
Publicado: (2020)

The Rapid Coronavirus Antibody Test: Can We Improve Accuracy?
por: Pavlova, Ina P., et al.
Publicado: (2020)

Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer
por: Chakravarty, Dimple, et al.
Publicado: (2022)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Does Prostate Median Lobe Really Matter for GreenLight HPS Laser Photovaporization of the Prostate
por: Bodokh, Yohan, et al.
Publicado: (2018)

Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies
por: Dovey, Zachary S., et al.
Publicado: (2021)

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer
por: Gaglani, Simita, et al.
Publicado: (2021)

Circadian Rhythm Disruption as a Contributor to Racial Disparities in Prostate Cancer
por: Dasari, Sonali S., et al.
Publicado: (2022)

COVID-19 vaccination: Prioritization of at risk groups
por: Lundon, Dara J., et al.
Publicado: (2021)

Is night‐time surgical procedure for renal graft at higher risk than during the day? A single center study cohort of 179 patients
por: Treacy, Patrick Julien, et al.
Publicado: (2021)

Why do African–American men face higher risks for lethal prostate cancer?
por: Nair, Sujit S., et al.
Publicado: (2022)

A SelectMDx/magnetic resonance imaging‐based nomogram to diagnose prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2022)

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
por: Parekh, Sneha, et al.
Publicado: (2022)

Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
por: Rayford, Walter, et al.
Publicado: (2021)

Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable
por: Katims, Andrew B., et al.
Publicado: (2020)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

Early mortality risk stratification after SARS-CoV-2 infection
por: Lundon, D.J., et al.
Publicado: (2021)

Profiling Prostate Cancer Therapeutic Resistance
por: Wade, Cameron A., et al.
Publicado: (2018)

Mechanisms navigating the TGF-β pathway in prostate cancer
por: Cao, Zheng, et al.
Publicado: (2015)

The Impact of Frailty on Postoperative Cardiopulmonary Complications in the Emergency General Surgery Population
por: Akyar, Serra, et al.
Publicado: (2018)

Deciphering Evolutionary Dynamics and Lineage Plasticity in Aggressive Prostate Cancer
por: Kyprianou, Natasha, et al.
Publicado: (2021)

Anoikis in phenotypic reprogramming of the prostate tumor microenvironment
por: Nepali, Prerna R., et al.
Publicado: (2023)

Inflammation in prostate cancer progression and therapeutic targeting
por: Stark, Timothy, et al.
Publicado: (2015)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020)

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
por: Kahn, Barbara, et al.
Publicado: (2014)

Epigenetic mechanisms underlying subtype heterogeneity and tumor recurrence in prostate cancer
por: Chakraborty, Goutam, et al.
Publicado: (2023)

Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
por: Busetto, Gian Maria, et al.
Publicado: (2023)

A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
por: LACY, JOHN M., et al.
Publicado: (2014)

Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
por: Rastinehad, Ardeshir R., et al.
Publicado: (2019)

Leveraging 5G technology for robotic surgery and cancer care
por: Pandav, Krunal, et al.
Publicado: (2022)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
por: Dicken, Haley, et al.
Publicado: (2019)

Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study
por: Falagario, Ugo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7umb4b9cge5cmvjathftmbjr0u